Cardiac Drug Development Guide /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2003.
|
| Edition: | 1st ed. 2003. |
| Series: | Methods in Pharmacology and Toxicology,
|
| Subjects: |
Table of Contents:
- Cardiac Drug Development
- Novel Molecular Targets for Cardiac Drug Development
- The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discovery
- Oxygen Free Radicals in Heart Disease
- Mitogen-Activated Protein Kinases-Mediated Signaling in Cardiac Pathology
- Development of Anti-Inflammatory Drugs for Cardiovascular Disease
- Development and Use of Platelet Glycoprotein Antagonists in Heart Disease
- The Sodium-Hydrogen Exchange System in the Heart
- Nitric Oxide and Cardiac Ischemia
- Functional Endpoints Evaluating Cardiac Drug Activity
- Ionic Mechanisms of Atrial Fibrillation
- Targeting Ischemic Ventricular Arrhythmias
- Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease
- Heterologous Expression Systems and Screening Technologies in Ion Channel Drug Discovery
- Molecular Diversity of Ion Channels in the Mouse Heart
- Delayed Protection of the Myocardium
- Clinical Aspects in Cardiac Drug Development
- Cardiac Troponin Testing for Detection of Myocardial Infarction
- A Genetic Basis for Cardiac Arrhythmias
- Myocardial Adenoviral Vector Delivery for Cardiovascular Gene Therapy
- The Role of Pharmacometrics in Cardiovascular Drug Development
- Gender Differences in Heart Failure
- Angiogenesis Therapies for Coronary Artery Disease.